查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1625460

mRNA 疫苗和治療市場規模、佔有率、趨勢、行業分析報告（按類型、應用、治療類型、最終用戶和地區）- 市場預測，2025-2034 年

mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Treatment Type, End User, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球 mRNA 疫苗和治療市場預計到 2034 年將達到 2,538.3 億美元。該研究報告對當前市場動態提供了詳細的見解，並對未來市場成長進行了分析。

mRNA 疫苗和治療市場正在迅速發展，尤其是在 COVID-19 疫情爆發之後。信使 RNA (mRNA) 技術已成為 COVID-19 疫苗開發的一種方法，具有前所未有的速度和靈活性。這項創新為大流行期間快速生產疫苗鋪平了道路，並為未來針對流感、癌症和愛滋病毒等多種疾病的疫苗和治療具有巨大潛力。

傳統疫苗開發通常需要一個漫長的過程來識別最佳抗原、培養病毒樣本並生產大量疫苗。相較之下，mRNA 技術可以快速解碼病原體的遺傳密碼併合成編碼所需抗原的 mRNA。這意味著一旦知道基因序列，就可以針對任何傳染病快速開發出mRNA疫苗。這種能力促成了對 COVID-19 以外的其他疾病（例如流感和寨卡病毒）的 mRNA 疫苗的研究。

mRNA 療法正在被探索用於其他用途，特別是在腫瘤學領域。包括 Moderna 和 BioNTech 在內的多家公司已開始對基於 mRNA 的癌症疫苗進行臨床試驗，並取得了令人欣喜的早期結果。這些疫苗有可能用於治療多種癌症，既可以作為單一療法，也可以與化療或免疫療法等其他治療方法合併使用。

mRNA 疫苗和治療市場報告重點

根據應用，由於 mRNA 技術能夠透過開發個人化癌症疫苗和癌症免疫療法徹底改變癌症治療，預計腫瘤學領域將在預測期內實現快速成長。

按類型劃分，傳統的非擴增 mRNA 疫苗部分在 2024 年佔據了 mRNA 疫苗和治療市場的主導佔有率，這得益於其在 COVID-19 疫情期間被證明的功效和廣泛採用。

在全球市場中，由於強大的醫療保健基礎設施、對研發的大量投資以及 mRNA 技術的快速進步，預計北美將在 2024 年佔據最大的收入佔有率。

全球一些主要的市場參與者包括Pfizer Inc.; Moderna, Inc.; BioNTech SE; GlaxoSmithKline; Daiichi Sankyo; BioNTech SE; CureVac N.V.; AstraZeneca; Ethris; Sanofi; Arcturus Therapeutics; Innovac Therapeutics; Kernal Biologics; Pantherna Therapeutics; pHion Therapeutics; Recode Therapeutics; Rejuvenation Technologies; RNAimmune; Strand Therapeutics; Walvax; and Ziphius Vaccines.。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章 研究方法

第 4 章。
  • 市場概況
  • mRNA 疫苗與治療市場動態
    • 推動因素和機遇
      • 擴大研發、協作和策略夥伴關係 增加對基於 mRNA 的產品的監管批准
    • 阻礙因素和課題
      • 嚴格的監理標準
  • PESTEL 分析
  • mRNA 疫苗和療法的市場趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第 5 章。
  • 主要發現
  • 簡介
  • 自我擴增的 mRNA 疫苗
  • 傳統非擴增 mRNA 疫苗
6. 全球 mRNA 疫苗和治療市場（按應用）
  • 主要發現
  • 簡介
  • 癌症
  • 傳染病
  • 自體免疫疾病
  • 其他

7. 全球 mRNA 疫苗與治療市場（依治療類型劃分）

  • 主要發現
  • 簡介
  • 單株抗體
  • 基因治療
  • 細胞療法
  • 其他
8. 全球 mRNA 疫苗和治療市場（按最終用戶劃分）
  • 主要發現
  • 簡介
  • 調查研究機構
  • 醫院
  • 診所
  • 其他

第 9 章。
  • 主要發現
  • 簡介
    • mRNA 疫苗和治療市場評估：各地區，2020 年至 2034 年
  • 北美洲
      2020 年至 2034 年北美各類型
    • 2020 年至 2034 年北美各應用領域 北美，依治療類型，2020 年至 2034 年
    • 2020 年至 2034 年，北美地區終端用戶分佈
    • 美國
    • 加拿大
  • 歐洲
      2020 年至 2034 年歐洲各類型 2020 年至 2034 年歐洲應用狀況 2020 年至 2034 年歐洲各治療類型 2020 年至 2034 年歐洲終端用戶狀況
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
    亞太地區
      2020 年至 2034 年亞太地區各類產品 2020 年至 2034 年亞太地區應用情況 2020 年至 2034 年亞太地區治療類型 2020 年至 2034 年亞太地區最終用戶狀況
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
      2020 年至 2034 年中東和非洲各類型 2020 年至 2034 年中東和非洲的應用狀況 中東和非洲：依治療類型，2020 年至 2034 年 2020 年至 2034 年中東和非洲最終用戶狀況
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
      2020 年至 2034 年拉丁美洲各類型
    • 2020 年至 2034 年拉丁美洲各應用領域狀況 2020 年至 2034 年拉丁美洲各治療類型 2020 年至 2034 年拉丁美洲最終用戶狀況
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第 10 章 競爭格局

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協定/揭露

第 11 章 公司簡介

  • Pfizer Inc.
  • Moderna, Inc.
  • BioNTech SE
  • GlaxoSmithKline
  • Daiichi Sankyo
  • BioNTech SE
  • CureVac N.V.
  • AstraZeneca
  • Ethris
  • Sanofi
  • Arcturus Therapeutics
  • Innovac Therapeutics
  • Kernal Biologics
  • Pantherna Therapeutics
  • Ziphius Vaccines
Product Code: PM5328

The global mRNA vaccines and therapeutics market size is expected to reach USD 253.83 billion by 2034, according to a new study by Polaris Market Research. The report "mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Self-Amplifying mRNA-Based Vaccines and Conventional Non-Amplifying mRNA-Based Vaccines), Application, Treatment Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The mRNA vaccines and therapeutics market has seen a rapid evolution, particularly with the emergence of the COVID-19 outbreak. Messenger RNA (mRNA) technology emerged as an approach for COVID-19 vaccine development, offering unprecedented speed and flexibility. This innovation has created the way for rapid vaccine production during the pandemic and holds immense potential for future vaccines and therapeutics for a wide array of diseases such as influenza, cancer, and HIV.

Traditional vaccine development often requires lengthy processes to identify the most suitable antigens, grow virus samples, and produce large quantities of vaccine doses. In contrast, mRNA technology allows for rapid sequencing of a pathogen's genetic code, followed by the synthesis of mRNA that encodes the required antigen. This means that mRNA vaccines can be developed for any infectious disease as soon as its genetic sequence is known. This capability has prompted the exploration of mRNA vaccines for diseases beyond COVID-19, including influenza and Zika virus.

mRNA therapeutics are being explored for other applications, particularly in oncology. Several companies, including Moderna and BioNTech, have begun clinical trials for mRNA-based cancer vaccines, with promising early results. These vaccines may potentially be used to treat a variety of cancers, as standalone therapies or in combination with other treatments such as chemotherapy and immunotherapy.

mRNA Vaccines and Therapeutics Market Report Highlights

In terms of application, the cancer segment is expected to grow at a rapid pace during the forecast period owing to the ability of mRNA technology to revolutionize cancer treatment by enabling the development of personalized cancer vaccines and cancer immunotherapies.

Based on type, the conventional non-amplifying mRNA-based vaccines segment dominated the mRNA vaccines and therapeutics market share in 2024 owing to their proven efficacy and widespread adoption during the COVID-19 outbreak.

In the global market, North America held the largest revenue share in 2024 due to robust healthcare infrastructure, significant investments in research and development, and rapid advancements in mRNA technology.

A few of the global key market players are Pfizer Inc.; Moderna, Inc.; BioNTech SE; GlaxoSmithKline; Daiichi Sankyo; BioNTech SE; CureVac N.V.; AstraZeneca; Ethris; Sanofi; Arcturus Therapeutics; Innovac Therapeutics; Kernal Biologics; Pantherna Therapeutics; pHion Therapeutics; Recode Therapeutics; Rejuvenation Technologies; RNAimmune; Strand Therapeutics; Walvax; and Ziphius Vaccines.

Polaris Market Research has segmented the mRNA vaccines and therapeutics market report on the basis of type, application, treatment type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

  • Self-Amplifying mRNA-Based Vaccines
  • Conventional Non-Amplifying mRNA-Based Vaccines

By Application Outlook (Revenue, USD Billion, 2020-2034)

  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Others

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

  • Monoclonal Antibody
  • Gene Therapy
  • Cell Therapy
  • Other

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Research Laboratories and Organizations
  • Hospitals
  • Clinics
  • Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global mRNA Vaccines and Therapeutics Market Insights

  • 4.1. mRNA Vaccines and Therapeutics Market - Market Snapshot
  • 4.2. mRNA Vaccines and Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Research and Development (R&D), Collaborations, and Strategic Partnerships
      • 4.2.1.2. Increased Regulatory Approvals for mRNA-based Products
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Strict regulatory norms
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. mRNA Vaccines and Therapeutics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global mRNA Vaccines and Therapeutics Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Self-amplifying mRNA-based Vaccines
    • 5.3.1. Global mRNA Vaccines and Therapeutics Market, by Self-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)
  • 5.4. Conventional Non-amplifying mRNA-based Vaccines
    • 5.4.1. Global mRNA Vaccines and Therapeutics Market, by Conventional Non-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)

6. Global mRNA Vaccines and Therapeutics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Cancer
    • 6.3.1. Global mRNA Vaccines and Therapeutics Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 6.4. Infectious Diseases
    • 6.4.1. Global mRNA Vaccines and Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
  • 6.5. Autoimmune Diseases
    • 6.5.1. Global mRNA Vaccines and Therapeutics Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global mRNA Vaccines and Therapeutics Market, by Treatment Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 7.3. Monoclonal Antibody
    • 7.3.1. Global mRNA Vaccines and Therapeutics Market, by Monoclonal Antibody, by Region, 2020-2034 (USD Billion)
  • 7.4. Gene Therapy
    • 7.4.1. Global mRNA Vaccines and Therapeutics Market, by Gene Therapy, by Region, 2020-2034 (USD Billion)
  • 7.5. Cell Therapy
    • 7.5.1. Global mRNA Vaccines and Therapeutics Market, by Cell Therapy, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global mRNA Vaccines and Therapeutics Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 8.3. Research Laboratories and Organizations
    • 8.3.1. Global mRNA Vaccines and Therapeutics Market, by Research Laboratories and Organizations, by Region, 2020-2034 (USD Billion)
  • 8.4. Hospitals
    • 8.4.1. Global mRNA Vaccines and Therapeutics Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 8.5. Clinics
    • 8.5.1. Global mRNA Vaccines and Therapeutics Market, by Clinics, by Region, 2020-2034 (USD Billion)
  • 8.6. Others
    • 8.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global mRNA Vaccines and Therapeutics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. mRNA Vaccines and Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. mRNA Vaccines and Therapeutics Market - North America
    • 9.3.1. North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.3.3. North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.3.4. North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.3.5. mRNA Vaccines and Therapeutics Market - US
      • 9.3.5.1. US: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.3.5.2. US: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.3. US: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.3.5.4. US: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.3.6. mRNA Vaccines and Therapeutics Market - Canada
      • 9.3.6.1. Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4. mRNA Vaccines and Therapeutics Market - Europe
    • 9.4.1. Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.3. Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.4. Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.4.5. mRNA Vaccines and Therapeutics Market - UK
      • 9.4.5.1. UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.4.6. mRNA Vaccines and Therapeutics Market - France
      • 9.4.6.1. France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.3. France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.4.6.4. France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.4.7. mRNA Vaccines and Therapeutics Market - Germany
      • 9.4.7.1. Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.4.8. mRNA Vaccines and Therapeutics Market - Italy
      • 9.4.8.1. Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.4.9. mRNA Vaccines and Therapeutics Market - Spain
      • 9.4.9.1. Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.4.10. mRNA Vaccines and Therapeutics Market - Netherlands
      • 9.4.10.1. Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.4.11. mRNA Vaccines and Therapeutics Market - Russia
      • 9.4.11.1. Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.4.12. mRNA Vaccines and Therapeutics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5. mRNA Vaccines and Therapeutics Market - Asia Pacific
    • 9.5.1. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.5.5. mRNA Vaccines and Therapeutics Market - China
      • 9.5.5.1. China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.3. China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.5.5.4. China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.5.6. mRNA Vaccines and Therapeutics Market - India
      • 9.5.6.1. India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.3. India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.5.6.4. India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.5.7. mRNA Vaccines and Therapeutics Market - Malaysia
      • 9.5.7.1. Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.5.8. mRNA Vaccines and Therapeutics Market - Japan
      • 9.5.8.1. Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.5.9. mRNA Vaccines and Therapeutics Market - Indonesia
      • 9.5.9.1. Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.5.10. mRNA Vaccines and Therapeutics Market - South Korea
      • 9.5.10.1. South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.5.11. mRNA Vaccines and Therapeutics Market - Australia
      • 9.5.11.1. Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.5.12. mRNA Vaccines and Therapeutics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6. mRNA Vaccines and Therapeutics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.6.5. mRNA Vaccines and Therapeutics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.6.6. mRNA Vaccines and Therapeutics Market - UAE
      • 9.6.6.1. UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.6.7. mRNA Vaccines and Therapeutics Market - Israel
      • 9.6.7.1. Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.6.8. mRNA Vaccines and Therapeutics Market - South Africa
      • 9.6.8.1. South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.6.9. mRNA Vaccines and Therapeutics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7. mRNA Vaccines and Therapeutics Market - Latin America
    • 9.7.1. Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.7.5. mRNA Vaccines and Therapeutics Market - Mexico
      • 9.7.5.1. Mexico: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.7.6. mRNA Vaccines and Therapeutics Market - Brazil
      • 9.7.6.1. Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.7.7. mRNA Vaccines and Therapeutics Market - Argentina
      • 9.7.7.1. Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
    • 9.7.8. mRNA Vaccines and Therapeutics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Pfizer Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Moderna, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. BioNTech SE
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. GlaxoSmithKline
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Daiichi Sankyo
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. BioNTech SE
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. CureVac N.V.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. AstraZeneca
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Ethris
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Sanofi
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Arcturus Therapeutics
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Innovac Therapeutics
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Kernal Biologics
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Pantherna Therapeutics
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Ziphius Vaccines
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables:

Table 1 Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 2 Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 3 Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 4 Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 5 North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 6 North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 7 North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 8 North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 9 U.S.: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 10 U.S.: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 11 U.S.: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 12 U.S.: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 13 Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 14 Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 15 Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 16 Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 17 Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 18 Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 19 Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 20 Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 21 UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 22 UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 23 UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 24 UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 25 France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 26 France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 27 France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 28 France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 29 Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 30 Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 31 Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 32 Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 33 Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 34 Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 35 Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 36 Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 37 Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 38 Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 39 Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 40 Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 41 Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 42 Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 43 Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 44 Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 45 Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 46 Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 47 Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 48 Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 49 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 50 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 51 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 52 Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 53 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 54 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 55 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 56 Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 57 China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 58 China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 59 China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 60 China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 61 India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 62 India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 63 India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 64 India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 65 Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 66 Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 67 Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 68 Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 69 Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 70 Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 71 Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 72 Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 73 Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 74 Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 75 Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 76 Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 77 South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 78 South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 79 South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 80 South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 81 Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 82 Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 83 Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 84 Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 85 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 86 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 87 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 88 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 89 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 90 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 91 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 92 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 93 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 94 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 95 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 96 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 97 UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 98 UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 99 UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 100 UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 101 Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 102 Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 103 Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 104 Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 105 South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 106 South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 107 South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 108 South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 109 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 110 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 111 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 112 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 113 Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 114 Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 115 Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 116 Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 117 Mexico: mRNA vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 118 Mexico: mRNA vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 119 Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 120 Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 121 Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 122 Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 123 Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 124 Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 125 Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 126 Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 127 Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 128 Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 129 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 130 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 131 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 132 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global mRNA Vaccines and Therapeutics Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Type

Figure 7. Global mRNA Vaccines and Therapeutics Market, by Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Application

Figure 9. Global mRNA Vaccines and Therapeutics Market, by Application, 2024 & 2034 (USD Billion)

Figure 10. Market by Treatment Type

Figure 11. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2024 & 2034 (USD Billion)

Figure 12. Market by End User

Figure 13. Global mRNA Vaccines and Therapeutics Market, by End User, 2024 & 2034 (USD Billion)